Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are written automatically by software from each headline, not by an editor. They are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
- 8-K - Evommune, Inc. (0002044725) (Filer)
Automated noteEvommune, Inc. submitted a Form 8-K on September 9, 2026 (Accession No. 0001193125-26-385430) containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - FOOD CULTURE INC. (0001076262) (Filer)
Automated noteFood Culture Inc. filed a Form 8-K with the SEC on September 9, 2026, reporting an Item 8.01 “Other Events” disclosure (Accession No. 0001477932-26-005464).
- 8-K - TELEFLEX INC (0000096943) (Filer)
Automated noteTeleflex Inc. filed a Form 8-K on September 9, 2026, reporting director and officer departures, elections, appointments and related compensation arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - X4 Pharmaceuticals, Inc (0001501697) (Filer)
Automated noteX4 Pharmaceuticals, Inc. filed a Form 8-K with the SEC on September 9, 2026 (Accession No. 0001501697-26-000076), reporting Item 8.01 other events and Item 9.01 financial statements and exhibits.
- 8-K - Bit Digital, Inc (0001710350) (Filer)
Automated noteBit Digital, Inc. submitted a Form 8-K on September 9, 2026, containing a Regulation FD disclosure (Item 7.01) and accompanying financial statements and exhibits (Item 9.01).
- 8-K - Sound Point Meridian Capital, Inc. (0001930147) (Filer)
Automated noteSound Point Meridian Capital, Inc. filed a Form 8-K reporting an Item 8.01 Other Events on September 8 2026 (Accession No. 0001829126-26-009903).
- 8-K/A - Vivos Therapeutics, Inc. (0001716166) (Filer)
Automated noteVivos Therapeutics filed a Form 8-K amendment reporting entry into a material definitive agreement, unregistered sales of equity securities, and accompanying financial statements and exhibits.
- 8-K - Ellington Credit Co (0001560672) (Filer)
Automated noteEllington Credit Co filed a Form 8-K on September 8, 2026, including Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits.
- 8-K - Chime Financial, Inc. (0001795586) (Filer)
Automated noteChime Financial filed a Form 8-K on September 8, 2026, reporting entry into a material definitive agreement, providing a Regulation FD disclosure, and including financial statements and related exhibits.
- 8-K - Ellington Financial Inc. (0001411342) (Filer)
Automated noteEllington Financial Inc. filed a Form 8-K on September 8, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - MURPHY OIL CORP (0000717423) (Filer)
Automated noteMurphy Oil Corp filed a Form 8-K on September 8, 2026, containing a Regulation FD disclosure (Item 7.01) and accompanying financial statements and related exhibits (Item 9.01).
- 8-K - Ocugen, Inc. (0001372299) (Filer)
Automated noteOcugen, Inc. submitted a Form 8-K to the SEC on September 8 2026, containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - REPLIGEN CORP (0000730272) (Filer)
Automated noteRepligen Corp filed a Form 8-K with the SEC on September 8 2026, reporting under Item 8.01 (Other Events).
- 8-K - Nerdy Inc. (0001819404) (Filer)
Automated noteNerdy Inc. filed a Form 8-K on September 8, 2026 reporting the departure of certain directors or officers, the election and appointment of new directors and officers, and related compensatory arrangements for those officers.
- 8-K - Estrella Immunopharma, Inc. (0001844417) (Filer)
Automated noteEstrella Immunopharma, Inc. filed a Form 8-K reporting a notice of delisting or failure to meet a continued listing rule and a transfer of its listing.
- 8-K - Hepion Pharmaceuticals, Inc. (0001583771) (Filer)
Automated noteHepion Pharmaceuticals filed an 8-K reporting entry into a material definitive agreement, creation of a direct financial obligation/off-balance sheet arrangement, unregistered sales of equity securities, and accompanying financial statements and exhibits.
- 8-K - Stimcell Energetics Inc. (0001493712) (Filer)
Automated noteStimcell Energetics Inc. filed a Form 8-K on September 8, 2026, reporting entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Worthington Steel, Inc. (0001968487) (Filer)
Automated noteWorthington Steel, Inc. filed a Form 8-K on September 8, 2026, reporting entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - CONSTELLATION BRANDS, INC. (0000016918) (Filer)
Automated noteConstellation Brands, Inc. filed a Form 8-K on September 8, 2026, containing a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).
- 8-K - 5C Lending Partners Corp. (0001998387) (Filer)
Automated note5C Lending Partners Corp. filed a Form 8-K on September 8, 2026, reporting entry into a material definitive agreement, the creation of a direct financial obligation/off-balance-sheet arrangement, and accompanying financial statements and exhibits.
- 8-K - FREEPORT-MCMORAN INC (0000831259) (Filer)
Automated noteFreeport-McMoRan Inc. filed a Form 8-K with the SEC on September 8, 2026, reporting an Item 8.01 - Other Events disclosure (Accession No. 0000831259-26-000038, 143 KB).
- 8-K - Perspective Therapeutics, Inc. (0000728387) (Filer)
Automated notePerspective Therapeutics, Inc. filed an 8-K with the SEC on September 8, 2026 (Accession No. 0001193125-26-385362), containing Item 8.01 other events and Item 9.01 financial statements and exhibits.
- 8-K - SUNation Energy, Inc. (0000022701) (Filer)
Automated noteSUNation Energy filed a Form 8-K on September 8, 2026, reporting entry into a material definitive agreement and providing its financial statements and related exhibits.
- 8-K - UNITED THERAPEUTICS Corp (0001082554) (Filer)
Automated noteUnited Therapeutics filed a Form 8-K on September 8, 2026, reporting a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - SUNation Energy, Inc. (0000022701) (Filer)
Automated noteSUNation Energy, Inc. filed a Form 8-K on September 8, 2026, containing a Regulation FD disclosure (Item 7.01) and financial statements with related exhibits (Item 9.01).
- 8-K - Apnimed, Inc. (0001745648) (Filer)
Automated noteApnimed, Inc. filed a Form 8-K on September 8 2026, including Item 2.02 covering results of operations and financial condition and Item 9.01 providing financial statements and related exhibits.
- 8-K - AtaiBeckley Inc. (0002081043) (Filer)
Automated noteAtaiBeckley Inc. filed a Form 8-K on September 8, 2026, reporting that it has submitted certain matters to a vote of its security holders in accordance with Item 5.07.
- 8-K - Curaleaf Holdings, Inc. (0001756770) (Filer)
Automated noteCuraleaf Holdings, Inc. filed a Form 8-K with the SEC on September 8 2026 (Accession No. 0001756770-26-000095), including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
Automated noteBIO KEY INTERNATIONAL INC filed a Form 8-K reporting an Item 8.01 “Other Events” on September 8, 2026, accession number 0001437749-26-029849, with a document size of 157 KB.
- 8-K - Cactus, Inc. (0001699136) (Filer)
Automated noteCactus, Inc. filed a Form 8-K on September 8 2026, containing a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).